Risk of severe COVID-19 by age group for increased risk patients not accessing antiviral treatment— Mass General Brigham, June to December 2022. حسب Scott Dryden-Peterson (227433)

الموضوعات:

Equivalent elastic modulus of the capsule under case 1 and case 3. حسب Hongliang Zhang (149767)

Equivalent Poisson’s ratio of the capsule under case 1 and case 3. حسب Hongliang Zhang (149767)

Fig 1 - حسب Christian Karagiannidis (64152)

الموضوعات:

Estimated time-lags and case ascertainment for time-delay models fit to REACT-1 using the time series of daily cases. حسب Oliver Eales (11495186)

الموضوعات:

Characteristics of vaccinated population by anti-COVID-19 vaccine brand (27 December 2020–30 September 2021). حسب Cristina Morciano (9397154)

الموضوعات:

Case #5 حسب Bálint Lakatos (10535348)

Case #2 حسب Bálint Lakatos (10535348)

Scaled, pairwise relative Weighted Interval Score (rWIS; see <i>Methods</i> for description) by location for national and state/territory/DC forecasts, averaged across all horizons... حسب Velma K. Lopez (18510171)

Risk of severe COVID-19 by WHO risk groups for increased risk patients not accessing antiviral treatment— Mass General Brigham, June to December 2022. حسب Scott Dryden-Peterson (227433)

الموضوعات:

Risk of severe COVID-19 by NIH prioritization tier for increased risk patients not accessing antiviral treatment— Mass General Brigham, June to December 2022. حسب Scott Dryden-Peterson (227433)

الموضوعات:

Case #4 حسب Bálint Lakatos (10535348)

Case #3 حسب Bálint Lakatos (10535348)

LOH resulting in 189R/R produces a strong decrease in drug susceptibility. حسب Pétra Vande Zande (17628246)

Epidemiological curve of COVID-19 cases by generated starting date, the Netherlands, 27 February –1 June 2020 (n = 1,208). حسب Mitch van Hensbergen (11624798)

Summary statistics of daily COVID-19 cases (per 100,000 population) in each city. حسب Abdul Mueed (12436636)

الموضوعات:

Continuous ranked probability score relative to the score of the no-interaction model against increasing forecast horizon (one to four weeks). حسب James D. Munday (9756105)

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 5 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 4; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 4 while <i>SD</i> increases; 13^<i>th</i> scenario, lockdown and <i>SD</i> decrease. حسب Sara K. Al-Harbi (12418482)

"…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 5 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 4; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 4 while <i>SD</i> increases; 13^<i>th</i> scenario, lockdown and <i>SD</i> decrease.…"

Monthly distribution of COVID-19, influenza A/B, RSV and GAS cases during Seasons I and II. حسب Indrė Stacevičienė (11653912)

Validation of the selected models for the prediction of death in confirmed cases of COVID-19. حسب Wendy Nieto-Gutierrez (6029735)

الموضوعات: